136 related articles for article (PubMed ID: 27933222)
1. Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model.
Mammen A; Romanowski EG; Fedorchak MV; Dhaliwal DK; Shanks RM; Kowalski RP
Transl Vis Sci Technol; 2016 Dec; 5(6):12. PubMed ID: 27933222
[TBL] [Abstract][Full Text] [Related]
2. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
[TBL] [Abstract][Full Text] [Related]
3. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Sasaki H; Fukuda M; Gordon YJ
Jpn J Ophthalmol; 2008; 52(3):211-216. PubMed ID: 18661272
[TBL] [Abstract][Full Text] [Related]
4. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
[TBL] [Abstract][Full Text] [Related]
5. The comparison of fluoroquinolones to nonfluoroquinolone antibacterial agents for the prevention of endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Shanks RM; Mah FS
J Ocul Pharmacol Ther; 2012 Dec; 28(6):604-8. PubMed ID: 22925112
[TBL] [Abstract][Full Text] [Related]
6. Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis.
Kowalski RP; Romanowski EG; Shanks RMQ; Mammen A; Dhaliwal DK
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S338-S343. PubMed ID: 29944493
[TBL] [Abstract][Full Text] [Related]
7. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
de Castro LE; Sandoval HP; Bartholomew LR; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Apr; 22(2):132-8. PubMed ID: 16722799
[TBL] [Abstract][Full Text] [Related]
9. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ
J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin-loaded acrylic intraocular lenses: In vitro and in vivo performance.
Filipe HP; Bozukova D; Pimenta A; Vieira AP; Oliveira AS; Galante R; Topete A; Masson M; Alves P; Coimbra P; Gil MH; Guiomar AJ; Mata J; Colaço R; Saramago B; Werner L; Mamalis N; Serro AP
J Cataract Refract Surg; 2019 Dec; 45(12):1808-1817. PubMed ID: 31856994
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Staphylococcus epidermidis Endophthalmitis by Different Moxifloxacin Prophylaxis Routes.
Yovel OS; Ben Eliahu S; Kleinmann G
Curr Drug Deliv; 2016; 13(1):90-4. PubMed ID: 26324231
[TBL] [Abstract][Full Text] [Related]
12. Dual drug delivery from intraocular lens material for prophylaxis of endophthalmitis in cataract surgery.
Topete A; Serro AP; Saramago B
Int J Pharm; 2019 Mar; 558():43-52. PubMed ID: 30630077
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis.
Wu X; Chen H; Jiang H; Xu Y; Liu T; Xu L
J Ocul Pharmacol Ther; 2012 Apr; 28(2):186-93. PubMed ID: 22077488
[TBL] [Abstract][Full Text] [Related]
15. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
16. Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Cardillo JA; Paganelli F; Melo LA; Silva AA; Pizzolitto AC; Oliveira AG;
Arch Ophthalmol; 2010 Jan; 128(1):81-7. PubMed ID: 20065222
[TBL] [Abstract][Full Text] [Related]
17. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
Asena L; Akova YA; Goktaş MT; Bozkurt A; Yaşar U; Karabay G; Demiralay E
Curr Eye Res; 2013 Apr; 38(4):472-9. PubMed ID: 23373761
[TBL] [Abstract][Full Text] [Related]
18. Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.
Herrygers LA; Noecker RJ; Lane LC; Levine JM
Cornea; 2005 Jan; 24(1):66-71. PubMed ID: 15604869
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.
Abdel-Meguid AAE; Gabr AF; Said MM; Nassef MAEH; Elmenofy TMI
J Ocul Pharmacol Ther; 2019 Jun; 35(5):315-318. PubMed ID: 30950680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
